Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
CTX-10726 in Hepatocellular Carcinoma: NCT07419841 Clinical Landscape Report 2026
18 September 2026
NCT07419841 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Penpulimab in Triple Negative Breast Cancer: NCT07419880 Clinical Landscape Report 2026
18 September 2026
NCT07419880 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
APG-3288 in Recurrent Follicular Lymphoma: NCT07424833 Clinical Landscape Report 2026
18 September 2026
NCT07424833 clinical landscape for Recurrent Follicular Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CD19/BCMA CAR-T Cell(Wuhan Union Hospital) in Relapse multiple myeloma: NCT07429721 Clinical Landscape Report 2026
18 September 2026
NCT07429721 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mesna in Osteosarcoma: NCT07428993 Clinical Landscape Report 2026
18 September 2026
NCT07428993 clinical landscape for Osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine Hydrochloride in Bladder Cancer: ACTRN12626000234314 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000234314 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
cCTL(Obstetrics and Gynecology Hospital of Fudan University) in Female Genital Neoplasms: NCT07434284 Clinical Landscape Report 2026
18 September 2026
NCT07434284 clinical landscape for Female Genital Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Indocyanine Green in Carcinosarcoma: PACTR202602541023094 Clinical Landscape Report 2026
18 September 2026
PACTR202602541023094 clinical landscape for Carcinosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab tirumotecan in Renal Medullary Carcinoma: NCT07438626 Clinical Landscape Report 2026
18 September 2026
NCT07438626 clinical landscape for Renal Medullary Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Progesterone in Endometrial Endometrioid Adenocarcinoma: NCT07436793 Clinical Landscape Report 2026
18 September 2026
NCT07436793 clinical landscape for Endometrial Endometrioid Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
TAK-505 in Locally Advanced Malignant Solid Neoplasm: NCT07436728 Clinical Landscape Report 2026
18 September 2026
NCT07436728 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Enzomenib in Multiple Myeloma: NCT07444268 Clinical Landscape Report 2026
18 September 2026
NCT07444268 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.